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Infection with Leishmania amazonensis and other members of the Leishmania mexicana
complex can lead to diverse clinical manifestations, some of which are relatively difﬁcult
to control, even with standard chemotherapy. Diffuse cutaneous leishmaniasis (CL) is a
rare but severe form, and its clinical hallmark is excessive parasitic growth in infected
cells accompanied by profound impairments in host immune responses to the parasites.
Since these parasites also cause non-healing CL in most inbred strains of mice, these
animals are valuable models for dissecting the mechanisms of persistent infection and
disease pathogenesis. In comparison to other Leishmania species, L. amazonensis infec-
tions are most remarkable for their ability to repress the activation and effector functions of
macrophages, dendritic cells, and CD4+ T cells, implying discrete mechanisms at work. In
addition to thismultilateral suppression of host innate and adaptive immunity, the activation
of types I and II interferon-mediated responses and autophagic/lipid metabolic pathways
actually promotes rather than restrains L. amazonensis infection.These seemingly contra-
dictory ﬁndings reﬂect the remarkable adaptation of the parasites to the ancient defense
machinery of the host, as well as the complex parasite–host interactions at different stages
of infection, which collectively contribute to non-healing leishmaniasis in the New World.
This review article highlights new evidence that reveals the strategies utilized by L. ama-
zonensis parasites to subvert or modulate host innate defense machinery in neutrophils
and macrophages, as well as the regulatory roles of host innate responses in promot-
ing parasite survival and replication within the huge parasitophorous vacuoles. A better
understanding of unique features in host responses to these parasites at early and late
stages of infection is important for the rational design of control strategies for non-healing
leishmaniasis.
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INTRODUCTION
Leishmania amazonensis is a member of the Leishmania mexicana
complex and the etiological agent for a broad-spectrum of leish-
maniasis in SouthAmerican countries. It can causemild cutaneous
leishmaniasis (CL), diffuse CL (DCL), and deadly visceral leish-
maniasis (Silveira et al., 2004). DCL is a rare but severe form and is
not limited to patients in SouthAmerica. In patients withLeishma-
nia tropica and Leishmania major infections in India and Africa,
DCL is also considered a clinical indicator of HIV co-infection
(Niamba et al., 2007; Khandelwal et al., 2011). Generally speak-
ing, patients with DCL share some clinical characteristics. For
example, they have defective responses for the leishmanin skin test
and poor antigen-stimulated T cell proliferation in vitro, although
some patients remain responsiveness to other antigens such as
Abbreviations: Atg, autophagy-related genes; CL, cutaneous leishmaniasis; DCL,
diffuse cutaneous leishmaniasis; IFNAR, type I interferon-α receptor; ISCL, inos-
itol phosphosphingolipid phospholipase C-like; LYST/Beige, lysosomal trafﬁcking
regulator gene; PKR, dsRNA-dependent protein kinase; PS, phosphatidylserine; PV,
parasitophorous vacuoles; SOD1, superoxide dismutase 1; TCR, T cell receptor.
tuberculin and lepromin (Silveira et al., 2004). The mechanisms
responsible for this antigen-speciﬁc T cell anergy remain obscure,
although it is likely due to alterations in activation of dendritic
cells (DC) and macrophages (MΦ) following infection by L. ama-
zonensis. These profound impairments in cell-mediated immune
responses partially explain the relatively poor responses of DCL
patients to available anti-Leishmania chemotherapy.
Mouse models are important in understanding the biology of
leishmaniasis. The Th1/Th2 polarization of IFN-γ/IL-4 produc-
tion seen in L. major infection between resistant C57BL/6 and
susceptible BALB/c mice has provided valuable insights into pro-
tective and pathogenic mechanisms; however, this dogma is not
fully applicable to human diseases and to some other Leishmania
infection models (McMahon-Pratt and Alexander, 2004). L. ama-
zonensis infections in mice have several distinguished features. All
inbred strains of mice are genetically susceptible to L. amazonensis,
developing progressive non-healing lesions that contain charac-
teristic parasitophorous vacuoles (PV) and heavy parasite loads
(Soong et al., 1997). This generalized susceptibility is not linked to
a polarized expansion of IL-4-producing Th2 cells, but rather to
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the activation of pathogenic CD4+ T cells that produce relatively
low levels of IFN-γ, IL-10, IL-17, and other cytokines (Soong et al.,
1997; Xin et al., 2007). While knockout of endogenous IFN-γ or
IL-10 alone is insufﬁcient to changehost susceptibility to this infec-
tion, depletion of endogenous CD4+ T cells or adoptive transfer of
primed CD4+ T cells can deprive or exacerbate lesion pathogene-
sis, respectively (Soong et al., 1997; Xin et al., 2007). The low and
mixed Th1/Th2 responses seen in L. amazonensis-infected mice
are very similar to those observed in human infections (Silveira
et al., 2009), validating the biological relevance of these mouse
models for the study of human diseases.
Among the Leishmania species that are pathogenic to humans,
only L. amazonensis and other members in the L. mexicana com-
plex are capable of forming huge communal PV. It has been
proposed that the large PVs may serve as a “shield,” by diluting
the leishmanicidal effects of nitric oxide (NO) and reactive oxy-
gen species (ROS) in infected cells (Wilson et al., 2008); however,
additional studies are needed to verify this possibility. Compar-
ative studies with L. amazonensis promastigotes generated from
DCL and CL patients have revealed that DCL-derived parasites
tend to form big PVs with heavy infection in mouse MΦs, sug-
gesting a positive correlation between parasite virulence and PV
sizes (Franca-Costa et al., submitted). Under the cell-free condi-
tion, L. amazonensis parasites (especially the amastigote form) are
also more resistant to neutrophil- or MΦ-derived leishmanicidal
molecules than are their counterparts of other species (Mukbel
et al., 2007; Wang et al., 2011), possibly indicative of biological
features that are unique and intrinsic to these parasites.
The purpose of this review is not to provide a comprehensive
summary for the biology of Leishmania parasites or the pathogenic
roles of adaptive immune responses, as there are excellent reviews
covering these areas in this Special Topics issue for leishmaniasis.
Instead, this review will focus on new evidence that reveals the
strategies utilized by L. amazonensis parasites to down-modulate
and subvert host innate defense machinery in neutrophils and
MΦ, as well as the regulatory roles of host innate responses in
promoting parasite survival and infection in the host. These stud-
ies indicate complex roles of host immune responses toLeishmania
infections and open areas for further investigation.
L. AMAZONENSIS INFECTION CAN TRIGGER BROAD-RANGE
IMMUNOSUPPRESSION
As successful intracellular parasites that have a unique replication
niche, it is not surprising that Leishmania have developed multi-
faceted strategies to subvert or suppress MΦ’s defense machinery
(Osorio y Fortea et al., 2007; McConville and Naderer, 2011). It
is commonly thought that L. amazonensis parasites have evolved
additional mechanisms, some of which account for their uncon-
trolled replication in humans and in various strains of mice.
Although promastigotes of L. amazonensis can transiently trig-
ger DC and MΦ activation, the magnitude of cell activation,
and the spectrum of cytokine production are often much lower
than those triggered by promastigotes of L. major and Leishma-
nia braziliensis (Xin et al., 2007; Vargas-Inchaustegui et al., 2008).
Since these species-related differences are evident even at 12 h
of infection in vitro (Xin et al., 2007) or at 1 week of infection
in mice (Ji et al., 2003), several scenarios may account for the
deﬁcient immune responses againstL. amazonensis: these parasites
are either intrinsically potent in immune repression, antigeni-
cally weak in immune activation, or both. These hypotheses are
supported by the ﬁndings that promastigote antigens of L. ama-
zonensis (but not L. braziliensis) markedly inhibit mitogen- and
anti-CD3-induced T cell proliferation, and that such T cell anergy
cannot be reverted by exogenous cytokines (Pinheiro et al., 2004).
Likewise, vaccination with antigens of L. amazonensis (but not L.
braziliensis) preferentially stimulate IL-10 and TGF-β production,
leading to an increased susceptibility of vaccinated BALB/cmice to
L. amazonensis infection (Pinheiro et al., 2005). The mechanisms
underlying the promastigote species-speciﬁc differences remain
ambiguous.
The in situ and in vivo measurement of a large panel of
cytokines and chemokines and their corresponding receptors dur-
ingL. amazonensis infectionhas conﬁrmed that the early immuno-
suppressive status in antigen-presenting cells sets the stage for
impaired inﬂammatory responses and T cell responses. For exam-
ple, IL-1-related cytokines (IL-1α, IL-1β, and IL-1Rα) are rapidly
induced and tightly regulated in L. major-infected C57BL/6 (self-
healing) mice; however, these cytokines are barely induced even
at 4 weeks of infection with L. amazonensis (Ji et al., 2003). Sur-
prisingly, while IL-1βtreatment in vitro promotes the activation
of L. amazonensis-infected DCs and CD4+ T cells, such treatment
actually exacerbates lesionprogression andparasite growth inmice
(Xin et al., 2007), suggesting that the pathogenic condition may
not be readily reprogrammed by exogenous cytokines. To better
understand these pathogenic T cells, the Soong group compared
the frequency of cytokine-producing cells and their T cell receptor
(TCR) repertoires for CD4+ T cells isolated from non-healing (L.
amazonensis-infected) and self-healing (L. braziliensis-infected)
mice during primary and secondary infections. These different
sources of CD4+ T cells differ at the level of IFN-γ, IL-10, and
IL-17 production by the same TCR Vβ-barring subsets, implying
that the low magnitude of CD4+ T cell activation (rather than the
altered TCR diversity) is the determining factor for non-healing
disease caused by L. amazonensis (Xin et al., 2011).
Leishmania amazonensis amastigotes are superior in silent inva-
sion, forming huge PV, and preventing the activation of NK, DC,
andMΦ triggered by exogenous stimuli such as LPS (Soong, 2008;
Bhardwaj et al., 2010). The intracellular events triggered byL. ama-
zonensis infection inMΦs have been described in detail (Bhardwaj
et al., 2010; McConville and Naderer, 2011). The suppression of
host cell activation can be initiated at the stage of amastigote–
host contact. On one hand, L. amazonensis amastigotes can infect
human DCs through multiple receptor–ligand interactions such
as antibodies/Fc receptors, complement components/component
receptors, and proteoglycans/heparin-binding proteins (Bosetto
and Giorgio, 2007), leading to altered DC activation and impaired
responsiveness to exogenous stimuli through ERK/MAP kinase-
mediated mechanisms (Boggiatto et al., 2009). On the other hand,
L. amazonensis amastigotes can expose phosphatidylserine (PS)
on their surface, leading to enhanced parasite growth and host
suppression through IL-10 and TGF-β production by host cells
(Wanderley et al., 2006). The levels of PS exposure are relatively
high on lesion- andMΦ-derived amastigotes, but nearly absent on
axenic amastigotes, and are positively correlated to host immune
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responses (unpublished data). Although the origin of and the
conditions inducing PS exposure on amastigote surface are mat-
ters of investigation, modulating PS exposure is fundamental for
repressing host immune responses and granting survival for Leish-
mania parasites (Wanderley and Barcinski, 2010). This “apoptotic
mimicry” strategy is also important for other pathogens, includ-
ing Toxoplasma gondii and Vibrio cholerae (Thanawastien et al.,
2009; Dos Santos et al., 2011). No doubt, L. amazonensis can elicit
a broad-spectrum suppression against host innate and adaptive
immune responses, but low levels of host immune responses are
required for disease progression.
L. AMAZONENSIS PARASITES ARE PROFICIENT IN
UTILIZING HOST INNATE IMMUNE RESPONSES FOR THEIR
OWN GROWTH
Several lines of new evidence have revealed that L. amazonensis
parasites take advantage of host innate defense machinery in neu-
trophils andMΦs for their own infection. The ﬁrst one is related to
the utilization of host type I interferons (IFN). The Soong group
has shown that signaling through type I IFNs and IFN-α receptor
(IFNAR) actually favors L. amazonensis infection, rather than pro-
motes its control (Xin et al., 2010). As shown in Figure 1, L. ama-
zonensis-infected IFNAR−/− mice developedmuch smaller lesions
that contained lower numbers of parasites than did wild-type con-
trols. Even at 3 days post-infection, parasite growth was restrained
in IFNAR−/− mice but exacerbated in IFN-α-treated mice, imply-
ing a regulatory role for type I IFNs in this infection model. Along
the same line, it is known that IFNAR−/− mice are also more resis-
tant to intracellular bacteria such as Listeria monocytogenes and
Mycobacterium tuberculosis (Rayamajhi et al., 2010a,b). In the case
of L. amazonensis infection, the disease-promoting effect of type
I IFNs is multifarious, correlating with the functions and inter-
actions of neutrophils and MΦs. For instance, IFN-α prolongs
the life span of un-infected and infected neutrophils, whereas the
deletion of IFNAR decreases the survival of neutrophils (andmost
likely the survival of promastigotes; Xin et al., 2010). Importantly,
the lack of IFNAR signaling promotes the differential recruitment
and activation of neutrophils and inﬂammatory monocytes, as
well as restrains parasite infection in MΦs that are co-cultured
FIGURE 1 |The IFNAR signaling promotes L. amazonensis infection in
mice. (A) IFNAR−/− mice developed smaller lesions that contained lower
parasite loads than did wild-type controls. (B)The infection-promoting effect
of IFN-a was detectable at 3 days post-infection. The lack of IFNAR signaling
restrained parasite infection at early stages of the infection. Adapted from
Xin et al. (2010).
with neutrophils (Xin et al., 2010). Therefore, New World leish-
maniasis caused by L. amazonensis and L. guyanensis infections
are exacerbated by the production of type I IFNs (Xin et al., 2010;
Ives et al., 2011). During Leishmania infection, type I IFN produc-
tion can be triggered by TLR9-dependent responses to Leishmania
genomic DNA or TLR3-dependent responses to Leishmania RNA
virus-1 or exposure to other dsRNA viruses (Liese et al., 2007; Ives
et al., 2011). The pathogenic role of type I IFNs is supported by the
ﬁndings that exogenous IFN-β stimulates superoxide dismutase 1
(SOD1) and impairs the superoxide-dependent killing of L. ama-
zonensis and L. braziliensis in human MΦ, playing a deleterious
role in CL (Khouri et al., 2009). Since type I IFNs are known to
play a protective role in infections against L. major, L. braziliensis,
and Leishmania infantum infections (Liese et al., 2008), careful
evaluation is needed for the functions of type I IFNs in murine
and human leishmaniasis.
The second line of evidence is related to the utilization of
TLR2-mediated responses for parasite growth. While MyD88 is
required for the effective control of L. amazonensis andL. brazilien-
sis infections, signaling throughTLR2 seems to have a regulatory
role, favoring these infections (Vargas-Inchaustegui et al., 2009;
Guerra et al., 2010). In the absence of TLR2, DC, and CD4+
T cells display an elevated activation and enhanced production
of IL-12, IL-10, and IFN-γcytokines. Lesions of TLR2−/− mice
had reduced numbers of neutrophils and MΦs, but increased
numbers of eosinophils. As a consequence, TLR2−/− mice have
attenuated lesions following infection with L. braziliensis (Vargas-
Inchaustegui et al., 2009) and L. amazonensis (Guerra et al., 2010;
unpublished data).
Mechanistically, the disease-promoting effects of IFNAR and
TLR2 appear to be linked to the initial intracellular events trig-
gered by parasite infection. The elegant studies conducted by the
Lopes group have shown that infection with promastigotes of L.
amazonensis leads to the activation of an interferon-dependent
expression of dsRNA-dependent protein kinase (PKR), a classic
antiviral protein, and that treatment of infected mouse MΦs with
the synthetic dsRNA poly(I:C), a potent PKR inductor, increases
parasite intracellular growth through an IL-10-mediated mech-
anism (Pereira et al., 2010). More recently, the same group also
found that L. amazonensis and lipophosphoglycan, the major sur-
face component of promastigotes, induce the activationof the PKR
promoter by a TLR2-dependent manner, and that TLR2−/− MΦs
express low IFN-β and PKR levels with reduced parasite loads,
while IFN-α treatment promotes the growth of L. amazonensis
promastigotes (de Carvalho Vivarini et al., 2011). Importantly,
lesions of DCL patients displayed higher levels of PKR/type I
IFN-expressing cells compared with those from single CL patients,
indicating an important and regulatory role for type I IFNs and
TLR2 in human leishmaniasis (de Carvalho Vivarini et al., 2011).
How type I IFNs and TLR2 execute their regulatory roles at the
early and late stages of L. amazonensis infection remain unclear.
In the cases of L. monocytogenes and M. tuberculosis infections,
host susceptibility is known to be associated with the antagonistic
crosstalk between type I and type II IFNs, as IFN-α/β can impair
MΦ activation and their responsiveness to IFN-γ (Rayamajhi et al.,
2010b). Also, type I IFN singling can inﬂuence the phenotypes of
MΦ subsets, as well as their responsiveness to a range of cytokines
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that use STAT1 (IFN-γ, IL-10, IL-6, M-CSF, CCL5, and CXCL10;
Fleetwood et al., 2009). Given that exogenous pro-inﬂammatory
cytokines (IFN-α/β, IFN-γ, IL-1β), regulatory cytokines (TGF-β,
IL-10), and insulin-like growth factor-1 all have the potential to
promote L. amazonensis infection in vitro and/or in mice (Ven-
drame et al., 2007; Wanasen et al., 2007; Xin et al., 2007), it is
reasonable to speculate that the low level and crosstalk of these
host cytokines create a microenvironment, which is exploited by
these parasites for efﬁcient entry and intracellular growth.
L. AMAZONENSIS PARASITES CAN EXPLOIT HOST’S LIPID
METABOLISM AND ENDOCYTIC/AUTOPHAGIC PATHWAYS
Autophagy is an ancient mechanism for recycling aged organelles
or proteins, and an intrinsic antimicrobial defense for pathogen
killing and antigen presentation. Signaling pathways triggered
throughTLR3/4/7/8 and pro-inﬂammatory cytokines (IFN-α/β/γ,
TNF-α, IL-1β) can induce canonical macro-autophagy charac-
terized by the double-membrane autophagosome, leading to
the clearance of most viruses and bacteria and the presenta-
tion of microbial antigens (Delgado et al., 2009; Deretic, 2011).
However, some pathogens can override or exploit this innate
defense machinery for their favored growth (Deretic and Levine,
2009). The successful intracellular pathogens often have mul-
tipronged strategies to avoid autophagolysosomal degradation
and/or dampen autophagy-dependent activation of host immune
responses. In Leishmania research, autophagy is known to be criti-
cally important for parasite stage differentiation and development
(Besteiro et al., 2006; Williams et al., 2009); however, it is largely
unclear as to how host cell autophagy affects Leishmania infec-
tion and how replicating parasites manipulate host autophagic
pathways. Several recent studies have suggested a unique ability
of L. amazonensis to circumvent the host’s lipid metabolism and
endocytic/autophagic pathways.
First, L. amazonensis parasites can selectively manipulate host
cell lipid biosynthesis pathways.Wilson et al. (2008) have reported
that L. amazonensis promastigote infection can up-regulate the
lysosomal trafﬁcking regulator gene (LYST/Beige) in MΦs, and
that up- or down-regulation of the LYST/Beige gene in MΦs
and ﬁbroblasts directly modulates PV sizes and parasite growth.
At present, the deﬁnitive roles for and regulation of LYST/Beige
expression during in vivo infection have not been demonstrated.
Recently, Osorio y Fortea et al. (2009) conducted large-scale,
transcriptional signature analyses of amastigote-free MΦ and
amastigote-harboringMΦ at 24 h after the uptake of nudemouse-
derived L. amazonensis amastigotes. Their data indicate that
amastigote infection preferentially up-regulates the function of
lipid metabolism, especially the canonical metabolic pathway
of biosynthesis of steroids, as well as the polyamine pathways.
Therefore, while these replicating amastigotes repress host cell
activation in general, they can selectively exploit the host cell’s
lysosomal trafﬁcking and sterol biosynthesis machinery for their
own cell membrane sterols and for the sterol-dependent remod-
eling and expansion of the PV membrane. However, these tran-
scriptomes proﬁles represent early host–parasite interactions in
the absence of host cytokines and components that are often
detected in the lesion microenvironment or on the amastigote
surface.
To address the functional role of host phospholipids and
ceramides in parasite infection, the Zhang group generated Leish-
mania parasites that are deﬁcient in the degradation of host
sphingolipid, due to the deletion of the inositol phosphosphin-
golipid phospholipase C-like (ISCL) protein. They found that the
iscl-null mutants of L. major completely abolished their virulence
in BALB/cmice, partially due to parasite’s defects in survival under
an acid pH condition; however, a low number of mutant para-
sites could persist in the injection site for several months (Zhang
et al., 2009; Xu et al., 2011). In sharp contrast, the iscl-deﬁcient
L. amazonensis are fully virulent in BALB/c mice, but are partially
attenuated inC57BL/6mice (K. Zhang,personal communication).
The striking differences in disease outcomes following infection
with iscl-deﬁcient L. major and L. amazonensis in BALB/c mice
suggest that ISCL is an essential virulence factor for L. major ;
however, L. amazonensis may have additional, ISCL-independent
mechanisms for survival within the acidiﬁed PV.
Second,L. amazonensis amastigote-harboring PVs are enriched
with nutrients, but are not augmented with microbicidal func-
tion of the lysosome. Osorio y Fortea et al. (2009) reported the
infection-induced gene expression of eight isoforms of the V0
and V1 sub-units of the MΦ vacuolar proton ATPase, support-
ing the notion that amastigote-harboring PVs are highly acidi-
ﬁed and optimal for amastigote nutrient acquisition (McConville
and Naderer, 2011). Most notably, L. amazonensis amastigote-
harboring PVs are quite special, as they can fuse with vacuoles
that carry L. major promastigote but not amastigotes. L. major
promastigotes within these chimeric PVs can temporarily survive
and multiply, but fail to differentiate into amastigotes (Real et al.,
2010). Therefore, the mature PV of L. amazonensis is not the
compartment with a license to kill. Furthermore, L. amazonen-
sis amastigote-harboring PVs can efﬁciently fuse with vacuoles
that carry Coxiella burnetii, the causative agent of human Q fever.
Importantly, L. amazonensis amastigotes, as well as wild-type and
mutant C. burnetii deﬁcient in their ability of lysosomal reno-
vation, can replicate comfortably within these chimeric vacuoles
(Rabinovitch andVeras, 1996; Beare et al., 2011). The ﬁndings that
L. amazonensis and C. burnetii replicate in fusogenic vacuoles are
intriguing. It is plausible that both pathogens can block themicro-
bicidal function of the lysosome and acquire nutrients by continu-
ous fusion and/or membrane transport with other compartments
in the secretory and endolysosomal systems (McConville and
Naderer, 2011; Newton and Roy, 2011). At this stage, it remains to
be a big challenge and a big prize to cell biologists to isolate and
study the protein and lipid composition of Leishmania PV. One
hypothesis may be incompleteness of PVmembrane for ROS pro-
ducing machinery after L. amazonensis infection. An assessment
of absolute NO or ROS levels in Leishmania-carrying PVs versus
lysosomes and phagosomes formed after engulfment of bacteria
and latex beads will shield some light in this area.
Lastly, factors that induceMΦ autophagy can promote L. ama-
zonensis infection. In mammalian cells, autophagy induction is
regulated by sequential activation of regulators, the formation
of Atg complexes and autophagosomes, and the maturation of
autolysosomes. Although IFN-γ treatment (10∼ 100 ng/ml) is
known to increase PV sizes and L. amazonensis amastigote loads in
mouse MΦs in an arginase-independent manner (Wanasen et al.,
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2007), theunderlyingmechanism is ambiguous.Recently,Pinheiro
et al. (2009) have shown that autophagy induction via IFN-γ or
starvation increased L. amazonensis but not L. major infection in
BALB/c MΦs; however, this was not the case in C57BL/6 MΦs.
Since L. amazonensis amastigotes do not co-localize with IFN-
γ-induced, double-membrane vacuoles (Pinheiro et al., 2009), it
is plausible that IFN-γ, starvation, or autophagy-inducing drugs
may create a vacuolar environment that is generally permissive
for engulfment and replication of the parasites. Information on
whether and how Leishmania parasites alter, modulate, and uti-
lize host autophagic pathways is needed. Additional studies with
mutant parasites, in the context of genetic and/or pharmacological
perturbation in the host autophagic pathway and lipid metabo-
lism, will uncover the parasites’ intrinsic ability of utilizing host
cell resources and exploiting host defense mechanisms for their
favored intracellular growth.
CONCLUDING REMARKS
The emerging evidence from recent studies has uncovered the
complex host–Leishmania interactions. A detrimental regulatory
loop at very early stages of the infection with L. amazonensis can
lead to the activation and expansion of pathogenic CD4+ T and
B cells and non-healing lesions. Figure 2 is a schematic diagram,
illustrating key regulatory events at the level of neutrophils and
MΦs that collectively contribute to the exacerbated L. amazonensis
infection. Firstly, the IFNAR-mediated signaling augments the dif-
ferential recruitment and activation of neutrophils and inﬂamma-
tory monocytes, as well as the prolonged survival of neutrophils,
the potential Trojan horses for parasite spread toMΦ (Jochim and
Teixeira, 2009). Secondly, type I IFNs contribute to parasite infec-
tion by impairing the superoxide-dependent killing of parasites in
MΦ and simulatingPKR-mediatedproductionof IL-10 in infected
MΦs. Thirdly, pro-inﬂammatory cytokines such as IFN-γcan turn
on the host cell autophagic pathway and lipidmetabolism, thereby
creating a microenvironment that favors parasite entry or replica-
FIGURE 2 | A schematic diagram illustrates the interplays between
innate immune cells and the regulatory roles of key cytokines during
infection with Leishmania amazonensis. Modulation of intracellular
pathways by host and/or parasite factors can lead to enlarged vacuoles and
enhanced parasite growth.
tion. Further validation of the cross-talking by using immunolog-
ical, genetic, and pharmacological approaches will be important.
For the study of innate immune responses in vivo, another issue
of consideration is the differences in local responses triggered by
needle- versus sandﬂy-delivered parasites (see other reviews in this
Special Topic).A better understanding of howdifferent species and
stages of Leishmania parasites can selectively utilize host innate
defense machinery and adoptive immunity for immune evasion,
intracellular growth, and immunopathogenesis will lead to the
rational design of control strategies for this and other related
infections.
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